Evox Therapeutics’ £69.2 Million Series C Financing Round

Goodwin Procter LLP advised Evox Therapeutics on the deal.Evox Therapeutics,  leading exosome therapeutics company, announced its £69.2 million Series C financing round. The financing was significantly oversubscribed…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now